Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -20.9% | -14158.1% | 0 / 3 | -24.3% | -5.60 pp | -4.35 pp | -0.5% | 0.03 | — | 31,1 | −24,3% | −3,6 | −22,1% | — | 5.44 | — |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.700 (close price on 2026-10-16)EPS (TTM): −78,0
Financial charts
1.Revenue & growth
VND bn31,1Q2/26
1.Revenue & growth
VND bn31,1Q2/26
2.Profit & growth
VND bn-3,53Q2/26
3.Profit mix (Penman)
VND bn-3,35Q2/26
4.Margins & cost structure
%15.2%Q2/26
5.Returns & cash cycle
% · days0.8%Q2/26
6.Earnings quality & cash
VND bn235Q2/26
7.Asset structure
VND bn801Q2/26
8.Funding & debt health
VND bn · times801Q2/26
9.Revenue backlog
VND bn18,2Q2/26
10.Valuation
times · %-21,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-82Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-21227%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26